Researchers suggest GI physicians should question patients about their use of over-the-counter medications, including nonsteroidal anti-inflammatory drugs, in order to help their interpretation of capsule endoscopy findings, according to a study published in Clinical Gastroenterology and Hepatology.
Researchers found that of the patients who underwent capsule endoscopy in their study, 13.6 percent took NSAIDs or aspirin but did not disclose that they were using those medications. Small bowel inflammation was found to be common among these patients and could be mistaken for Crohn's disease, highlighting the importance of clear medication history for accurate image interpretation.
Read the article about capsule endoscopy.
Read other coverage about capsule endoscopy:
- Remote-Controlled Capsule Endoscopy Safe and Effective for Screening
- 5 Things to Know About the Endoscopy Devices Market
- 6 Observations on the U.S. Market for GI Endoscopy Devices
Researchers found that of the patients who underwent capsule endoscopy in their study, 13.6 percent took NSAIDs or aspirin but did not disclose that they were using those medications. Small bowel inflammation was found to be common among these patients and could be mistaken for Crohn's disease, highlighting the importance of clear medication history for accurate image interpretation.
Read the article about capsule endoscopy.
Read other coverage about capsule endoscopy:
- Remote-Controlled Capsule Endoscopy Safe and Effective for Screening
- 5 Things to Know About the Endoscopy Devices Market
- 6 Observations on the U.S. Market for GI Endoscopy Devices